Table 1.
Major criteria |
Treatment with continuous or near continuous (>50% of the year) oral corticosteroids |
Need for treatment with high-dose inhaled corticosteroids |
Minor criteria |
Need for additional daily treatment with a controller medication (long-acting β-agonist, leukotriene receptor antagonist, theophylline) |
Asthma symptoms needing short-acting β-agonist use on a daily or near daily basis |
Persistent airway obstruction (FEV1 < 80% predicted, diurnal peak expiratory flow variability >20% predicted) |
One of more urgent care visits for asthma per year |
Three or more oral steroid bursts per year |
Prompt deterioration with <25% reduction in oral or intravenous corticosteroid use |
Near fatal asthma event in the past |
One major criterion plus two minor criteria required for diagnosis; other diseases have been excluded, exacerbating factors treated, and patient is generally adherent.